Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice

被引:0
|
作者
Labow, M
Shuster, D
Zetterstrom, M
Nunes, P
Terry, R
Cullinan, EB
Bartfai, T
Solorzano, C
Moldawer, LL
Chizzonite, R
McIntyre, KW
机构
[1] DEPT NEUROCHEM & NEUROTOXICOL,ARRHENIUS LABS NAT SCI,STOCKHOLM,SWEDEN
[2] CHILDRENS HOSP PHILADELPHIA,ABRAMSON CTR,JOSEPH STOKES JR RES INST,PHILADELPHIA,PA 19104
[3] UNIV FLORIDA,COLL MED,DEPT SURG,GAINESVILLE,FL 32610
来源
JOURNAL OF IMMUNOLOGY | 1997年 / 159卷 / 05期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-1 alpha and IL-1 beta are potent inflammatory cytokines that contribute to a number of normal physiologic processes and to the development of a number of inflammatory diseases, Two IL-1R, the type I and type II receptors, have been identified, This work describes the derivation and characterization of mice deficient in expression of the type I IL-1R (IL-1RI), IL-1RI-deficient mice were viable and fertile, but failed to respond to IL-1 in a variety of assays, including IL-1-induced IL-6 and E-selectin expression and IL-1-induced fever, Similar to IL-1 beta-deficient mice, IL-1RI-deficient mice had a reduced acute phase response to turpentine, In contrast, IL-1RI-deficient mice had a reduced delayed-type hypersensitivity response and were highly susceptible to infection by Listeria monocytogenes, These data demonstrate that the IL-1RI is essential for all IL-1-mediated signaling events examined, and that both IL-1 alpha and IL-1 beta are critical to the animals' response to injury and infection, These data also demonstrate that IL-1 function is not required for normal development or homeostasis.
引用
收藏
页码:2452 / 2461
页数:10
相关论文
共 50 条
  • [41] Targeting IL-1 Receptor Signaling in AKI
    Steiger, Stefanie
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 34 (10): : 1601 - 1603
  • [42] Distinct mechanisms of IL-1 inhibition revealed by in vitro modeling of IL-1 receptor accessory protein interaction with IL-1/IL-1 receptor complex.
    Witt, A
    Vezina, C
    Qian, X
    Varnum, B
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S81 - S81
  • [43] IL-1 receptor accessory protein is an essential component of the IL-1 receptor
    Cullinan, EB
    Kwee, L
    Nunes, P
    Shuster, DJ
    Ju, G
    McIntyre, KW
    Chizzonite, RA
    Labow, MA
    JOURNAL OF IMMUNOLOGY, 1998, 161 (10): : 5614 - 5620
  • [44] Expression of IL-1β, IL-1 receptor type I and IL-1 receptor antagonist in human aortic smooth muscle cells:: Effects of all-trans-retinoic acid
    Wagsater, Dick
    Jatta, Ken
    Ocaya, Pauline
    Dimberg, Jan
    Sirsjo, Allan
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 (04) : 377 - 382
  • [45] IL-1 receptor type I expression in breast cancer
    Knüpfer, H
    Stanitz, D
    Brauckhoff, M
    Schmidt, R
    Knüpfer, MM
    Preiss, R
    BREAST, 2001, 10 (05): : 411 - 415
  • [46] Effects of IL-1 receptor accessory protein on IL-1 binding
    Wesche, H
    Resch, K
    Martin, MU
    FEBS LETTERS, 1998, 429 (03) : 303 - 306
  • [47] Roles of IL-1 and IL-1 receptor antagonist in the immune system
    Horai, R
    Asano, M
    Nakae, S
    Saijo, S
    Sudo, K
    Iwakura, Y
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 380 - 380
  • [48] IL-1 and TNF receptor-deficient mice show decreased. inflammation in an immune complex model of uveitis
    Brito, BE
    O'Rourke, LM
    Pan, YZ
    Anglin, J
    Planck, SR
    Rosenbaum, JT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (11) : 2583 - 2589
  • [49] A search within the IL-1 type I receptor reveals a peptide with hydropathic complementarity to the IL-1β trigger loop which binds to IL-1 and inhibits in vitro responses
    Heal, JR
    Bino, S
    Ray, KP
    Christie, G
    Miller, AD
    Raynes, JG
    MOLECULAR IMMUNOLOGY, 1999, 36 (17) : 1141 - 1148
  • [50] Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1β activity but not binding:: Regulation of IL-1 responses is via type I receptor, not the accessory protein
    Yoon, DY
    Dinarello, CA
    JOURNAL OF IMMUNOLOGY, 1998, 160 (07): : 3170 - 3179